89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

CUSIP: 282559103

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
+6,757,540
Put/Call ratio
27%
SEC-reported price per share
$5.79
Number of holders
84
Value change
+$45,497,652
Number of buys
60
Open additional details 1 more signal available
Number of sells
24
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
148,275,293

Security key

282559103

Report period

Q3 2022

Institutions

84

Top holders

10

Ownership snapshot

Top reported holders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5 13F Highest disclosed value: $25,060,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $25.06M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $21.09M
RA CAPITAL MANAGEMENT, L.P. $25.06M
BVF INC/IL $12.55M
Janus Henderson Group Ltd. $5.45M
Boxer Capital, LLC $4.51M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$21,093,397
1,829,436 shares
— 25 Jan 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$25,060,000
7,782,669 shares
— 30 Jun 2022
BVF INC/IL
13F
Company
13F
—
denominator unverified
$12,552,000
3,898,000 shares
— 30 Jun 2022
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$5,451,000
1,690,140 shares
— 30 Jun 2022
Boxer Capital, LLC
13F
Company
13F
—
denominator unverified
$4,508,000
1,400,000 shares
— 30 Jun 2022
GREAT POINT PARTNERS LLC
13F
Company
13F
—
denominator unverified
$4,508,000
1,400,000 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
84
Shares
39,211,413
Rows available
84
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
67
Q3 2022 holders
84
Holder diff
17
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .